Your browser doesn't support javascript.
loading
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study.
Stilgenbauer, Stephan; Eichhorst, Barbara; Schetelig, Johannes; Coutre, Steven; Seymour, John F; Munir, Talha; Puvvada, Soham D; Wendtner, Clemens-Martin; Roberts, Andrew W; Jurczak, Wojciech; Mulligan, Stephen P; Böttcher, Sebastian; Mobasher, Mehrdad; Zhu, Ming; Desai, Monali; Chyla, Brenda; Verdugo, Maria; Enschede, Sari Heitner; Cerri, Elisa; Humerickhouse, Rod; Gordon, Gary; Hallek, Michael; Wierda, William G.
Afiliación
  • Stilgenbauer S; Internal Medicine III, Ulm University, Ulm, Germany. Electronic address: Stephan.Stilgenbauer@uniklinik-ulm.de.
  • Eichhorst B; Department of Internal Medicine, Center of Integrated Oncology KölnBonn (CIO KölnBonn), and Cluster of Excellence on Cellular Stress Responses in Aging (CECAD), University of Cologne, Cologne, Germany.
  • Schetelig J; University Hospital, Technische Universität Dresden, Dresden, Germany.
  • Coutre S; Stanford University Medical Center, Stanford, CA, USA.
  • Seymour JF; Peter MacCallum Cancer Centre, and University of Melbourne, Melbourne, VIC, Australia.
  • Munir T; St James's University Hospital, Leeds, UK.
  • Puvvada SD; University of Arizona, Tucson, AZ, USA.
  • Wendtner CM; Klinikum Schwabing, Munich, Germany.
  • Roberts AW; Royal Melbourne Hospital, and University of Melbourne, Melbourne, VIC, Australia.
  • Jurczak W; Jagiellonian University, Krakow, Poland.
  • Mulligan SP; Royal North Shore Hospital, and University of Sydney, Sydney, NSW, Australia.
  • Böttcher S; University Hospital of Schleswig-Holstein, Campus Kiel, Second Department of Medicine, Kiel, Germany.
  • Mobasher M; Genentech, South San Francisco, CA, USA.
  • Zhu M; AbbVie, North Chicago, IL, USA.
  • Desai M; AbbVie, North Chicago, IL, USA.
  • Chyla B; AbbVie, North Chicago, IL, USA.
  • Verdugo M; AbbVie, North Chicago, IL, USA.
  • Enschede SH; AbbVie, North Chicago, IL, USA.
  • Cerri E; AbbVie, North Chicago, IL, USA.
  • Humerickhouse R; AbbVie, North Chicago, IL, USA.
  • Gordon G; AbbVie, North Chicago, IL, USA.
  • Hallek M; Department of Internal Medicine, Center of Integrated Oncology KölnBonn (CIO KölnBonn), and Cluster of Excellence on Cellular Stress Responses in Aging (CECAD), University of Cologne, Cologne, Germany.
  • Wierda WG; UT MD Anderson Cancer Center, Houston, TX, USA.
Lancet Oncol ; 17(6): 768-778, 2016 Jun.
Article en En | MEDLINE | ID: mdl-27178240
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Cromosomas Humanos Par 17 / Leucemia Linfocítica Crónica de Células B / Deleción Cromosómica / Terapia Recuperativa / Resistencia a Antineoplásicos / Compuestos Bicíclicos Heterocíclicos con Puentes / Recurrencia Local de Neoplasia / Antineoplásicos Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Cromosomas Humanos Par 17 / Leucemia Linfocítica Crónica de Células B / Deleción Cromosómica / Terapia Recuperativa / Resistencia a Antineoplásicos / Compuestos Bicíclicos Heterocíclicos con Puentes / Recurrencia Local de Neoplasia / Antineoplásicos Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article